Machine learning models for predicting postoperative peritoneal metastasis after hepatocellular carcinoma rupture: a multicenter cohort study in China.

Journal: The oncologist
PMID:

Abstract

BACKGROUND: Peritoneal metastasis (PM) after the rupture of hepatocellular carcinoma (HCC) is a critical issue that negatively affects patient prognosis. Machine learning models have shown great potential in predicting clinical outcomes; however, the optimal model for this specific problem remains unclear.

Authors

  • Feng Xia
  • Qian Chen
    Department of Pain Medicine Guizhou Provincial Orthopedics Hospital Guiyang Guizhou China.
  • Zhicheng Liu
    School of Biomedical Engineering, Capital Medical University, Beijing, China.
  • Qiao Zhang
    Beijing Hospital, Beijing, 100730, China.
  • Bin Guo
  • Feimu Fan
    Department of Hepatic Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
  • Zhiyuan Huang
    Department of Hepatic Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
  • Jun Zheng
    Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Hengyi Gao
    Department of Hepatobiliary and Pancreatic Surgery, Shenzhen Longhua District People's Hospital, Shenzhen, Guangdong, People's Republic of China.
  • Guobing Xia
    Department of Hepatobiliary and Pancreatic Surgery, Huangshi Central Hospital, Hubei Polytechnic University, Huangshi, Hubei, People's Republic of China.
  • Li Ren
    School of Communication and Information Engineering, Nanjing University of Posts and Telecommunications, Nanjing, 210003.
  • Hongliang Mei
    Department of General Surgery, General Hospital of Central Theater Command, Wuhan, Hubei, People's Republic of China.
  • Xiaoping Chen
    Clinical Medical College, Yangzhou University, 225009 Yangzhou, Jiangsu, China; Department of Anesthesiology, Institute of Anesthesia, Emergency and Critical Care, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, 225002 Yangzhou, Jiangsu, China.
  • Qi Cheng
    Institute of Intelligent System and Bioinformatics, College of Intelligent Systems Science and Engineering, Harbin Engineering University, Harbin, China.
  • Bixiang Zhang
    Department of Surgery, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China. bixiangzhang@163.com.
  • Peng Zhu
    Center for Drug Safety Evaluation and Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.